Comparison
Alpha-GPC vs Donepezil (Aricept)
Alpha-GPC
The most bioavailable common choline source. About 40% of an oral dose reaches the brain within an hour, where it serves as substrate for acetylcholine synthesis and as a phospholipid membrane component. The de facto pairing for every racetam stack.
Donepezil (Aricept)
Prescription acetylcholinesterase inhibitor for Alzheimer's disease. Reversible AChE inhibition prolongs synaptic acetylcholine.
| Field | Alpha-GPC | Donepezil (Aricept) |
|---|---|---|
| Category | cholinergic | cholinergic |
| Dose range | 300–600mg | 5–23mg |
| Half-life | 6h | 70h |
| Onset | 30min | 180min |
| Evidence | EVIDENCEA | EVIDENCEA |
| Safety | ●●●●● | ●●●○○ |
| Legal (US) | USOTC | USRx |
| PubMed refs | 320 | 6800 |
The comparison in plain English
Auto-generated from dataAlpha-GPC and Donepezil (Aricept) are both in the cholinergic category respectively. Alpha-GPC The most bioavailable common choline source. Donepezil (Aricept) Prescription acetylcholinesterase inhibitor for Alzheimer's disease.
Bottom line
Alpha-GPC (evidence A, safety 5/5) matches the evidence base of Donepezil (Aricept) (evidence A, safety 3/5). Alpha-GPC has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Alpha-GPC if
Alpha-GPC is the better fit when your goal aligns with its mechanism (Rapidly absorbed and cleaved into choline and glycerophosphate) and the dose range (300–600mg) suits your protocol. Half-life is 6h.
Choose Donepezil (Aricept) if
Donepezil (Aricept) is the better fit when your goal aligns with its mechanism (Reversibly inhibits acetylcholinesterase in the central nervous system, preventing acetylcholine breakdown and prolonging cholinergic synaptic signaling) and the dose range (5–23mg) suits your protocol. Half-life is 70h.